- Home
- GROW vs OTLK Comparison
GROW vs OTLK Comparison
Compare GROW & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROW
- OTLK
- Stock Information
- Founded
- GROW 1968
- OTLK 2010
- Country
- GROW United States
- OTLK United States
- Employees
- GROW 26
- OTLK N/A
- Industry
- GROW Investment Managers
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GROW Finance
- OTLK Health Care
- Exchange
- GROW Nasdaq
- OTLK Nasdaq
- Market Cap
- GROW 33.1M
- OTLK 33.6M
- IPO Year
- GROW N/A
- OTLK 2016
- Fundamental
- Price
- GROW $2.45
- OTLK $2.01
- Analyst Decision
- GROW
- OTLK Strong Buy
- Analyst Count
- GROW 0
- OTLK 6
- Target Price
- GROW N/A
- OTLK $28.68
- AVG Volume (30 Days)
- GROW 22.4K
- OTLK 1.8M
- Earning Date
- GROW 02-06-2025
- OTLK 02-12-2025
- Dividend Yield
- GROW 3.63%
- OTLK N/A
- EPS Growth
- GROW N/A
- OTLK N/A
- EPS
- GROW 0.12
- OTLK N/A
- Revenue
- GROW $10,008,000.00
- OTLK N/A
- Revenue This Year
- GROW N/A
- OTLK N/A
- Revenue Next Year
- GROW N/A
- OTLK N/A
- P/E Ratio
- GROW $20.22
- OTLK N/A
- Revenue Growth
- GROW N/A
- OTLK N/A
- 52 Week Low
- GROW $2.38
- OTLK $0.87
- 52 Week High
- GROW $2.95
- OTLK $12.85
- Technical
- Relative Strength Index (RSI)
- GROW 53.57
- OTLK 40.39
- Support Level
- GROW $2.41
- OTLK $1.26
- Resistance Level
- GROW $2.45
- OTLK $1.59
- Average True Range (ATR)
- GROW 0.04
- OTLK 0.20
- MACD
- GROW 0.00
- OTLK 0.18
- Stochastic Oscillator
- GROW 62.50
- OTLK 81.52
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.